H
HBIO
Harvard Biosci
8.24
+0.11+1.35%After Hours: 8.24 0.00 0.00%16:04 10/09 EDT
OPEN/PREV CLOSE8.10/8.13
TODAY RANGE8.10-8.47
VOL12.40K
MARKET CAP37.51M
52 WEEK RANGE3.755-9.40
AVG VOL (3M)18.07K
% TURNOVER0.26%
TURNOVER--
P/E (TTM)-3.5470
% RANGE4.00%
EPS(TTM)-2.3231
P/E(FORWARD)-4.2365
P/B5.06
BVPS1.630
DIVIDEND--
P/S0.4258
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP33.99M
SHARES OUTSTANDING4.55M
NEXT EARNINGS11/04-11/09
FREE FLOAT4.12M
LOT SIZE1
EX-DATE03/16/2026
News
Press Releases
Financial Reports
Profile
TipRanks·09/15 20:05
Harvard Bioscience management to meet with KeyBanc
TipRanks·08/24 12:35
Twelve option delistings on August 24th
Dow Jones·08/12 13:08
Harvard Bioscience Price Target Raised to $7.50/Share From $6.00 by Benchmark
Dow Jones·08/12 13:08
Harvard Bioscience Is Maintained at Speculative Buy by Benchmark
NASDAQ·08/11 13:34
Harvard Bioscience's Q2 Revenue Rises 11%; Raises FY26 Growth Outlook
TipRanks·08/11 11:32
Harvard Bioscience Advances Transformation with Project Viking Launch
Seeking Alpha·08/11 11:24
Harvard Bioscience beats top-line and bottom-line estimates; gives Q3 and raises FY2026 outlook
Dow Jones·08/11 11:10
*Harvard Bioscience Sees 3Q Rev $21M-$22.6M >HBIO
Dow Jones·08/11 11:10
*Harvard Bioscience Sees 2026 Revenue Growth of 3% to 5% >HBIO
Benzinga·08/11 11:05
Harvard Bioscience Sees FY2026 Sales $89.147M-$90.877M vs $88.600M Est.
Benzinga·08/11 11:03
Harvard Bioscience Sees Q3 Sales $21.000M-$22.600M vs $21.850M Est
Dow Jones·08/11 11:01
Press Release: Harvard Bioscience Announces -2-
Dow Jones·08/11 11:01
Press Release: Harvard Bioscience Announces Second Quarter 2026 Financial Results
Dow Jones·08/11 11:01
*Harvard Bioscience 2Q Adj Loss/Shr 14c >HBIO